Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

Phase 2 Not yet recruiting 90 enrolled Second Affiliated Hospital, School of Medicine, Zhejiang University

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Objective: This study aimed to analyze the outcomes of post-infectious olfactory dysfunction treated with different doses of corticosteroids and specify factors related to the curative effect. Methods: The medical records of patients diagnosed with post-infectious olfactory dysfunction from January 2020 to december 2025 were reviewed. All patients were treated with different doses of oral corticosteroids for 12 days or they inhaled corticosteroids for 1 month.

Timeline

Start: 2021-06-02
Primary completion: 2025-12-30
Completion: 2026-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Budesonide	Small molecule	1 mg	Intranasal
Subject	Methylprednisolone	Other / unclassified	4 mg	Oral
Subject	Methylprednisolone	Other / unclassified	8 mg	Oral

Indications

No indication recorded.